.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Novartis
Boehringer Ingelheim
Chubb
Medtronic
Merck
Daiichi Sankyo
Fish and Richardson
Citi

Generated: July 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074262

« Back to Dashboard
NDA 074262 describes TIMOLOL MALEATE, which is a drug marketed by Usl Pharma, Apotex Inc, Akorn, Watson Labs, Pacific Pharma, Teva, Sandoz, Fdc Ltd, Sandoz Inc, Hi Tech Pharma, Quantum Pharmics, Fougera, Mylan, Wockhardt, and Bausch And Lomb, and is included in thirty-eight NDAs. It is available from thirteen suppliers. There is one patent protecting this drug. Additional details are available on the TIMOLOL MALEATE profile page.

The generic ingredient in TIMOLOL MALEATE is timolol maleate. There are fifteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.

Summary for NDA: 074262

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074262

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 074262

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC 074262 ANDA Physicians Total Care, Inc. 54868-3714 54868-3714-1 10 mL in 1 BOTTLE, PLASTIC (54868-3714-1)
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC 074262 ANDA Physicians Total Care, Inc. 54868-3714 54868-3714-2 5 mL in 1 BOTTLE, PLASTIC (54868-3714-2)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.5% BASE
Approval Date:Apr 28, 1995TE:AT1RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Dow
Deloitte
US Army
Cantor Fitzgerald
Argus Health
Boehringer Ingelheim
Moodys
Accenture
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot